Zentiva S.A. Logo

Zentiva S.A.

Develops and manufactures affordable generic, OTC, and biosimilar medicines.

SCD | RO

Overview

Corporate Details

ISIN(s):
ROSCDBACNOR8
LEI:
254900HN31MYF870PE70
Country:
Romania
Address:
THEODOR PALLADY, 032266 BUCUREȘTI, SECTORUL 3

Description

Zentiva is an international pharmaceutical company that develops, manufactures, and delivers a wide range of high-quality, affordable medicines. The company's portfolio includes generic pharmaceuticals, over-the-counter (OTC) products, and biosimilars. Serving over 100 million people in more than 30 countries, Zentiva focuses on increasing patient access to essential treatments, primarily across Europe and other global markets. The company is committed to providing health and wellbeing solutions for all generations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 16:49
Raport Financiar Trimestrial - RFT
English 550.4 KB
2025-05-15 16:47
Raport Financiar Trimestrial - RFT
Romanian 648.8 KB
2025-04-30 16:13
Raport curent de informare a investitorilor
Romanian 222.1 KB
2025-04-30 13:55
Raport Financiar Anual - RFA
English 819.1 KB
2025-04-30 13:54
Raport Financiar Anual - RFA
Romanian 702.8 KB
2025-02-28 10:30
REZULTATE FINANCIARE PRELIMINARE
English 262.6 KB
2025-02-28 10:29
REZULTATE FINANCIARE PRELIMINARE
Romanian 334.2 KB
2025-02-21 14:24
Convocarea adunarii generale a actionarilor - RC11
Romanian 570.2 KB
2025-02-21 14:02
Schimbari in conducerea societatii comerciale - RC09
Romanian 660.1 KB
2024-06-13 16:22
Raportare tranzactii parti afiliate in conformitate cu art.92 ind.3 din Legea 2…
English 128.3 KB
2024-05-15 17:19
Raport Financiar Trimestrial - RFT
English 452.7 KB
2024-05-15 17:18
Raport Financiar Trimestrial - RFT
Romanian 467.9 KB
2024-04-29 14:28
Raport curent de informare a investitorilor
English 111.4 KB
2024-04-29 11:53
Litigii in care este implicata societatea comerciala - RC08
English 123.9 KB
2024-03-21 11:05
Convocarea adunarii generale a actionarilor - RC11
English 184.0 KB

Automate Your Workflow. Get a real-time feed of all Zentiva S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zentiva S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zentiva S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.